NCT04302324 2026-05-20A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to DaratumumabWeill Medical College of Cornell UniversityPhase 2 Active not recruiting11 enrolled 15 charts